A 56-year-old man achieves remission from aggressive stage 4 non-Hodgkin's lymphoma after undergoing innovative CAR-T cell therapy at Medanta Hospital, overcoming prior treatment failures and serious ...

DelveInsight's “Hairy Cell Leukemia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth ...

While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...